Halozyme Reports First Quarter 2016 Financial Results

Go back to Halozyme Reports First Quarter 2016 Financial Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 70.14 +1.15 (1.67%)
Previous Close $68.99    52 Week High $18.39 
Open $69.38    52 Week Low $6.96 
Day High $70.20    P/E N/A 
Day Low $68.93    EPS $-0.58 
Volume 461,447